The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure

F Angeli, M Zappa, G Reboldi, G Gentile… - European Journal of …, 2023 - Elsevier
Among the various comorbidities potentially worsening the clinical outcome in patients
hospitalized for the acute respiratory syndrome coronavirus-2 (SARS-CoV-2), hypertension …

Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB. 1.16

M Zappa, P Verdecchia, F Angeli - European Journal of Internal …, 2023 - ejinme.com
The World Health Organisation (WHO) estimated 780 million severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections and approximately 6.9 million deaths …

[HTML][HTML] Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection

F Angeli, M Zappa, P Verdecchia - European journal of internal medicine, 2024 - Elsevier
Several reports documented a specific effect of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) on blood pressure (BP), during and after the acute phase of …

Rethinking the role of the renin-angiotensin system in the pandemic era of SARS-CoV-2

F Angeli, M Zappa, P Verdecchia - Journal of cardiovascular …, 2023 - mdpi.com
After assessing the levels of spread and severity of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, academic literature focused on the pathophysiology …

Complications of SARS-CoV-2 Infection During Cardiac Rehabilitation: A Case Series

M Zappa, P Verdecchia, A Andolina, A Spanevello… - Cardiology and …, 2023 - Springer
Introduction Vaccination strongly reduces the risk of hospitalization and death due to
coronavirus disease 2019 (COVID-19). However, the severity of the acute respiratory …

[PDF][PDF] Complications of SARS-CoV-2 Infection During Cardiac Rehabilitation: A Case Series

MZPVA Andolina, ASF Angeli - METHODS, 2023 - scienceopen.com
Introduction: Vaccination strongly reduces the risk of hospitalization and death due to
coronavirus disease 2019 (COVID-19). However, the severity of the acute respiratory …

[PDF][PDF] A COMBINED VIRTUAL SCREENING OF COMPOUNDS FROM CARICA PAPAYA LEAVES AGAINST THE SARS-CORONAVIRUS-2 PROTEIN TARGET

SIAN FERNANDES - 2022 - academia.edu
Objective: The coronavirus known as severe acute respiratory syndrome (SARS)-Cov-2 was
a new strain that had generated a pandemic that was spreading due to an increase in cases …

[PDF][PDF] The identification of potential inhibitors of SARS-CoV-2 spike protein by virtual screening FDA-approved compound library

Z Ren, D Zeng, P Wang, R Wang, B Zhou, Y Zhang - 2022 - cancercellresearch.org
Coronavirus disease 2019 (COVID-19) has an unprecedented global health crisis and
economic disruptive impact, which is initiated by the spike protein of severe acute respiratory …

[引用][C] The new phase of pandemic: Are BA. 2.75 and BQ. 1 competitive variants? An in silico evaluation

M Zappa, P Verdecchia, F Angeli - European journal of internal …, 2023 - ejinme.com
To the Editor In the new phase of pandemic, Omicron BA. 5 is still the most dominant strain
of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the European …